Our findings show that laminarin can counteract diet-induced hyperlipidemia by reducing intestinal cholesterol uptake, possibly through the down-regulation of NPC1L1 expression, a key transporter for cholesterol uptake. The gene discussed is NPC1L1; the disease is hyperlipidemia.